Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ju Yeon Choi

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
The Journal of Infectious Diseases|November 29, 2024
Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational StudyHyun Myung Kang, Hye-Jin Kim, Jiwon Jung, et al.
Journal of Medical Virology|December 23, 2023
Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variantsBeomki Lee, Jae-Hoon Ko, Yong Chan Kim, et al.
Frontiers in Cellular and Infection Microbiology|July 28, 2022
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination SchedulesJu-Yeon Choi, Young Jae Lee, Jae-Hoon Ko, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2022
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicitySeongman Bae, Jae-Hoon Ko, Ju-Yeon Choi, et al.
Frontiers in Immunology|October 10, 2022
Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South KoreaEliel Nham, Jae-Hoon Ko, Kyoung-Ho Song, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
The Journal of Infectious Diseases|November 29, 2024
Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational StudyHyun Myung Kang, Hye-Jin Kim, Jiwon Jung, et al.
Journal of Medical Virology|December 23, 2023
Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variantsBeomki Lee, Jae-Hoon Ko, Yong Chan Kim, et al.
Frontiers in Cellular and Infection Microbiology|July 28, 2022
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination SchedulesJu-Yeon Choi, Young Jae Lee, Jae-Hoon Ko, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2022
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicitySeongman Bae, Jae-Hoon Ko, Ju-Yeon Choi, et al.
Frontiers in Immunology|October 10, 2022
Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South KoreaEliel Nham, Jae-Hoon Ko, Kyoung-Ho Song, et al.
Pageof 10